°¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®
Infection Surveillance Solution Market Report: Trends, Forecast and Competitive Analysis
»óǰÄÚµå : 1416643
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 - page report
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,800 £Ü 8,392,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,700 £Ü 9,694,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,850 £Ü 12,805,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå µ¿Çâ ¹× Àü¸Á

¼¼°è °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 13.1%ÀÇ ¼ºÀå·ü·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© 2030³â ¾à 13¾ï 9,710¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº º´¿ø ³» °¨¿°ÀÇ È®»ê, Ç×±Õ °ü¸® ÇÁ·Î±×·¥ äÅà Áõ°¡, ¼ö¼ú °Ç¼öÀÇ ±ÞÁõÀÔ´Ï´Ù. ¼¼°è °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀåÀÇ ¹Ì·¡´Â Àå±â¿ä¾ç½Ã¼³°ú º´¿ø ½ÃÀå¿¡¼­ ±âȸ°¡ ÀÖ¾î À¯¸ÁÇØ º¸ÀÔ´Ï´Ù.

°¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå¿¡ ´ëÇÑ ÀλçÀÌÆ®

LucintelÀº ¿¹Ãø ±â°£ µ¿¾È ¼­ºñ½º°¡ ´õ¿í ³ôÀº ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÔ¿øÀÌ ÇÊ¿äÇÑ Àα¸ Áõ°¡·Î ÀÎÇØ º´¿øÀº ÀÌ ½ÃÀå¿¡¼­ °¡Àå Å« ºÎ¹®ÀÌ µÉ °ÍÀÔ´Ï´Ù.

¾ÆÅÂÁö¿ªÀº Áö¿ª ³» ÀÇ·á°ü±¤ÀÌ Å©°Ô ¼ºÀåÇϰí ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÇ¸é¼­ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÚÁÖ ¹¯´Â Áú¹®

Q.1 °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå ±Ô¸ð´Â?

A1. ¼¼°è °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀåÀº 2030³â±îÁö ¾à 13¾ï 9,710¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q.2 °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀå Àü¸ÁÀº ´ÙÀ½°ú °°½À´Ï´Ù.

A2. ¼¼°è °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 13.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q.3 °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀº?

A3. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº º´¿ø ³» °¨¿°ÀÇ È®»ê, Ç×±Õ °ü¸® ÇÁ·Î±×·¥ äÅà Áõ°¡, ¼ö¼ú °Ç¼öÀÇ ±ÞÁõÀÔ´Ï´Ù.

Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.

A4. °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀåÀÇ ¹Ì·¡´Â Àå±â¿ä¾ç½Ã¼³°ú º´¿ø ½ÃÀå¿¡¼­ÀÇ ±âȸ°¡ ÀÖ¾î À¯¸ÁÇØ º¸ÀÔ´Ï´Ù.

Q5. ½ÃÀå ÁÖ¿ä ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

A5. ÁÖ¿ä °¨¿° °¨½Ã ¼Ö·ç¼Ç ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

Q6. ÇâÈÄ °¡Àå Å« ½ÃÀå ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.

A6.LucintelÀº ¿¹Ãø ±â°£ µ¿¾È ¼­ºñ½º°¡ ´õ¿í ³ôÀº ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

Q7. ½ÃÀå¿¡¼­ ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº ¾îµðÀԴϱî?

A7. ¾Æ½Ã¾ÆÅÂÆò¾çÀº Áö¿ª ³» ÀÇ·á°ü±¤ÀÌ Å©°Ô ¼ºÀåÇϰí ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÇ¸é¼­ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q8. º¸°í¼­ »ç¿ëÀÚ Á¤Àǰ¡ °¡´ÉÇմϱî?

A8. ³×. LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ °¨¿° °¨½Ã ¼Ö·ç¼Ç ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2030³â)

Á¦4Àå Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2023³â)

Á¦5Àå °æÀï ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·«Àû ºÐ¼®

Á¦7Àå À¯·Â ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Infection Surveillance Solution Market Trends and Forecast

The future of the global infection surveillance solution market looks promising with opportunities in the long term care facility and hospital markets. The global infection surveillance solution market is expected to reach an estimated $1,397.1 million by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are rising prevalence of hospital-acquired infections, growing adoption of antimicrobial stewardship programs, and surging number of surgeries.

A more than 150-page report is developed to help in your business decisions.

Infection Surveillance Solution Market by Segment

The study includes a forecast for the global infection surveillance solution market by product and services, infection type, end use industry, and region

Infection Surveillance Market by Product and Services [Shipment Analysis by Value from 2018 to 2030]:

Infection Surveillance Market by Infection Type [Shipment Analysis by Value from 2018 to 2030]:

Infection Surveillance Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

Infection Surveillance Market by Region [Shipment Analysis by Value from 2018 to 2030]:

List of Infection Surveillance Solutions Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infection surveillance solutions companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infection surveillance solutions companies profiled in this report include-

Infection Surveillance Solutions Market Insights

Lucintel forecasts that service is expected to witness higher growth over the forecast period.

Within this market, hospitals will remain the largest segment due to increasing prevalence of chronic disease and rising number of people requied hospitalization.

APAC is expected to witness highest growth over the forecast period due to significantly growing medical tourism and improving healthcare infrastructure in the region.

Features of the Global Infection Surveillance Solution Market

Market Size Estimates: Infection surveillance solution market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Infection surveillance solution market size by product and services, infection type, end use industry, and region in terms of value ($B).

Regional Analysis: Infection surveillance solution market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product and services, infection types, end use industries, and regions for the infection surveillance solution market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infection surveillance solution market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is theinfection surveillance solution market size?

Answer: The global infection surveillance solution market is expected to reach an estimated $1397.1 million by 2030.

Q.2 What is the growth forecast for infection surveillance solution market?

Answer: The global infection surveillance solution market is expected to grow with a CAGR of 13.1% from 2024 to 2030

Q.3 What are the major drivers influencing the growth of the infection surveillance solution market?

Answer: The major drivers for this market are rising prevalence of hospital-acquired infections, growing adoption of antimicrobial stewardship programs, and surging number of surgeries.

Q4. What are the major segments for infection surveillance solution market?

Answer: The future of the infection surveillance solution market looks promising with opportunities in the long term care facilities, and hospitalsmarkets.

Q5. Who are the key infection surveillance solution market companies?

Answer: Some of the key infection surveillance solutions companies are as follows:

Q6. Which infection surveillance solution market segment will be the largest in future?

Answer: Lucintel forecasts that service is expected to witness higher growth over the forecast period.

Q7. In infection surveillance solution market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to significantly growing medical tourism and improving healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global Infection Surveillance Solution Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2018 to 2030

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â